Novozymes Invests More Than $36 Million To Expand Its Cary, North Carolina, R&D Center
04/23/2014
The planned facility will specifically support Novozymes bioagriculture business. The company plans to create 100 jobs over the next three years in Wake County. Scientists at the new site will research and develop beneficial microorganisms found in the soil. The resulting technology will focus on improved yield, fertility and pest control for growers around the world.
The company uses nature’s technology to re-engineer thousands of everyday products and deliver enhanced performance, reduced energy, chemical and raw material costs and reduced waste streams for its customers.
Novozymes’ bio-solutions enable everything from more drought tolerant crops to cold water laundry washing to advancements in renewable energy. The company currently employs 545 full-time workers in Franklin County.
“This is a new day in agriculture. Our growing world population and changing diets demand more crops from our arable land with less inputs. By substantially boosting our research and commercialization of environmentally-friendly microbial technology, we will help farmers meet this demand in a sustainable way for the benefit of agriculture, consumers, the environment and society at large,” said Adam Monroe, Novozymes President for the Americas. “We thank the state of North Carolina and our various partners for their support as we work to grow this important part of our business. We look forward to our expanded presence in North Carolina and continuing the great relationships we have in this state.”
“The research and development jobs Novozymes will create will further strengthen our hi-tech hub and be an example of the strong talent pool and attractive quality of life that characterizes Wake County, the Research Triangle and the state,” said Governor Pat McCrory.
“With one of the fastest growing economies in our state, Cary and Wake County are leading the way in the Carolina Comeback,” said Secretary Sharon Decker. “Cutting edge research and development in the biotechnology field will attract even more of the best and brightest minds to North Carolina.”
The project was made possible in part by a performance-based grant from the One North Carolina Fund of up to $400,000. The One NC Fund provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state. Companies receive no money up front and must meet job creation and investment performance standards to qualify for grant funds. These grants also require and are contingent upon local matches.
Partners that helped with this project include: the North Carolina Department of Commerce, N.C. Community Colleges, North Carolina Biotechnology Center, Cary Economic Development, the Town of Cary, Capital Area Workforce Development Board, Wake County Economic Development, Franklin County Economic Development Commission, Franklin County, Wake Technical Community College, UNC-Chapel Hill, and N.C. State University.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024